Long-term results of RTOG trial 8911 (USA intergroup 113): A random assignment trial comparison of chemotherapy followed by surgery compared with surgery alone for esophageal cancer

Journal of Clinical Oncology

Volumn 25, Issue 24, 2007, Pages 3719-3725

  Kelsen, David P ^a   Winter, Katryn A ^a   Gunderson, Leonard L ^a   Mortimer, Joanne ^a   Estes, Norman C ^a   Haller, Daniel G ^a   Ajani, Jaffer A ^a   Kocha, Walter ^a   Minsky, Bruce D ^a   Roth, Jack A ^a   Willett, Christopher G ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; FLUOROURACIL;

ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE FREE SURVIVAL; ESOPHAGUS CANCER; FEMALE; HEALTH CARE ORGANIZATION; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; OVERALL SURVIVAL; POSTOPERATIVE CARE; PREOPERATIVE CARE; PRIORITY JOURNAL; PROGNOSIS; RELAPSE; SURVIVAL RATE; TREATMENT RESPONSE; TUMOR REGRESSION;

ADENOCARCINOMA; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SQUAMOUS CELL; CISPLATIN; DISEASE-FREE SURVIVAL; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; FEMALE; FLUOROURACIL; HUMANS; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; SURVIVAL RATE;

EID: 34548516386     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2006.10.4760     Document Type: Article

References (21)

1. Kelsen DP, Ginsberg R, Pajak T, et al: Chemotherapy followed by surgery compared with surgery alone for localized esophageal cancer. N Engl J Med 339:1979-1984, 1998
2. Kaplan EL, Meier P: Non-parametric estimation from incomplete observation. J Am Stat 53:457-481, 1958
3. Mantel N: Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chem Rep 5:163-170, 1966
4. Kelsen DP, Heelan R, Coonley C, et al: Clinical and pathological evaluation of response to chemotherapy in patients with esophageal carcinoma. Am J Clin Oncol 6:539-546, 1983
5. Kato H, Tachimor Y, Watanabe H, et al: Anastomic recurrence of oesophageal squamous cell carcinoma after transthoracic oesophagectomy. Eur J Surg 164:759-764, 1998
6. Law S, Arcilla C, Chu KM, et al: The significance of histologically infiltrated resection margin after esophagectomy for esophageal cancer. Am J Surg 176:286-290, 1998
7. Sanz L, Gonzalez JJ, Miyar A, et al: Pattern of recurrence after esophageal resection for cancer. Hepato-Gastroenterology 46:2393-2397, 1999
8. Medical Research Council Oesophageal Cancer Working P: Surgical resection with or without preoperative chemotherapy in oesophageal: A randomized controlled trial. Lancet 359:1727-1733, 2002
9. Cunningham D, Allum WH, Stenning SP, et al: Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med 355:11-20, 2006
10. Van Cutsem E, Moiseyenko VM, Tjulandin S, et al: Phase III study of docetaxel and cisplatin plus fluorouracil compared with cisplatin and fluorouracil as first-line therapy for advanced gastric cancer: A report of the V325 Study Group. J Clin Oncol 24: 4991-1997, 2006
11. Dank M, Zaluski J, Barone C, et al: Randomized phase III trial of irinotecan (CPT-11) + 5FU/ folinic acid (FA) vs CDDP + 5Fu in 1st line advanced gastric cancer patients. J Clin Oncol 23:308s, 2005 (abstr 4003)
12. Baselga J: Herceptin alone or in combination with chemotherapy in the treatment of HER2-positive metastatic breast cancer: Pivotal trials. Oncology 61:14-21, 2001 (suppl 2)
13. Heinrich MC, Corless CL, Demetri GD, et al: Kinase mutations and imatinib response in patients with metastatic gastrointestinal stromal tumor. J Clin Oncol 21:4342-4349, 2003
14. Lynch TJ, Bell DW, Sordella R, et al: Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib. N Engl J Med 350:2129-2139, 2004
15. Mellinghoff IK, Wang MY, Vivanco I, et al: Molecular determinants of the response of glioblastomas to EGFR kinase inhibitors. N Engl J Med 353:2012-2024, 2005
16. Luthra R, Wu T-T, Lutra MG, et al: Gene expression profiling of localized esophageal carcinomas: Association with pathologic response to preoperative chemoradiation. J Clin Oncol 24:259-267, 2006
17. Ott K, Fink U, Becker K, et al: Prediction of response to preoperative chemotherapy in gastric carcinoma by metabolic imaging: Results of a prospective trial. J Clin Oncol 21:4604-4610, 2003
18. Weber WA: Use of PET for monitoring cancer therapy and for predicting outcome. J Nucl Med 46:983-995, 2005
19. Lordick F: Response-guided treatment in locally advanced adenocarcinoma of the esophagogastric junction (AEG): Survival results and cost analysis of the MUNICON trial. Presented at the American Society of Clinical Oncology Gastrointestinal Cancer Symposium January 19-21, 2007, Orlando, FL
20. Stahl M, Stuschke M, Lehmann N, et al: Chemoradiation with and without surgery in patients with locally advanced squamous cell carcinoma of the esophagus. J Clin Oncol 23:2310-2317, 2005
21. Bedenne L, Michel P, Bouche O, et al: Chemoradiation followed by surgery compared with chemoradiation alone in squamous cancer of the esophagus: FFCD 9102. J Clin Oncol 25:1160-1168, 2007